Balchem Corp (BCPC) stock
BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 19/3015% above fair value
$173.14+0.79 (+0.46%)
Close on Nov 13, 2026Market cap $5.50BP/E 32.6Yield 0.55%
Balchem EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Balchem's EPS for the twelve months ending Sep 30, 2026 was $5.31, up 16.2% year over year. For fiscal 2025 it was $4.75, up 20.9% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $4.75 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.75 | +20.9% |
| FY2024 | Dec 31, 2024 | $3.93 | +17.3% |
| FY2023 | Dec 31, 2023 | $3.35 | +3.1% |
| FY2022 | Dec 31, 2022 | $3.25 | +10.5% |
| FY2021 | Dec 31, 2021 | $2.94 | +13.1% |
| FY2020 | Dec 31, 2020 | $2.60 | +6.1% |
| FY2019 | Dec 31, 2019 | $2.45 | +1.2% |
| FY2018 | Dec 31, 2018 | $2.42 | -13.3% |
| FY2017 | Dec 31, 2017 | $2.79 | +59.4% |
| FY2016 | Dec 31, 2016 | $1.75 | -7.4% |
| FY2015 | Dec 31, 2015 | $1.89 | +11.8% |
| FY2014 | Dec 31, 2014 | $1.69 | +16.6% |
| FY2013 | Dec 31, 2013 | $1.45 | +9.8% |
| FY2012 | Dec 31, 2012 | $1.32 | +3.1% |
| FY2011 | Dec 31, 2011 | $1.28 | +14.3% |
| FY2010 | Dec 31, 2010 | $1.12 | +20.4% |
| FY2009 | Dec 31, 2009 | $0.93 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.46 | +17.7% |
| Q2 FY2026 | Jun 30, 2026 | $1.39 | +18.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.25 | +10.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.21 | +17.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.24 | +20.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.17 | +19.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.13 | +27.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.03 | +25.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.03 | +14.4% |
| Q2 FY2024 | Jun 30, 2024 | $0.98 | +5.4% |
| Q1 FY2024 | Mar 31, 2024 | $0.89 | +27.1% |
| Q4 FY2023 | Dec 31, 2023 | $0.82 | +24.2% |
| Q3 FY2023 | Sep 30, 2023 | $0.90 | +15.4% |
| Q2 FY2023 | Jun 30, 2023 | $0.93 | +1.1% |
| Q1 FY2023 | Mar 31, 2023 | $0.70 | -21.3% |
| Q4 FY2022 | Dec 31, 2022 | $0.66 | -13.2% |
| Q3 FY2022 | Sep 30, 2022 | $0.78 | +1.3% |
| Q2 FY2022 | Jun 30, 2022 | $0.92 | +31.4% |
| Q1 FY2022 | Mar 31, 2022 | $0.89 | +23.6% |
| Q4 FY2021 | Dec 31, 2021 | $0.76 | +11.8% |
| Q3 FY2021 | Sep 30, 2021 | $0.77 | +16.7% |
| Q2 FY2021 | Jun 30, 2021 | $0.70 | +7.7% |
| Q1 FY2021 | Mar 31, 2021 | $0.72 | +18.0% |
| Q4 FY2020 | Dec 31, 2020 | $0.68 | +7.9% |
| Q3 FY2020 | Sep 30, 2020 | $0.66 | +3.1% |
| Q2 FY2020 | Jun 30, 2020 | $0.65 | +6.6% |
| Q1 FY2020 | Mar 31, 2020 | $0.61 | +5.2% |
| Q4 FY2019 | Dec 31, 2019 | $0.63 | 0.0% |
| Q3 FY2019 | Sep 30, 2019 | $0.64 | +8.5% |
| Q2 FY2019 | Jun 30, 2019 | $0.61 | 0.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.58 | -3.3% |
| Q4 FY2018 | Dec 31, 2018 | $0.63 | -51.5% |
| Q3 FY2018 | Sep 30, 2018 | $0.59 | +18.0% |
| Q2 FY2018 | Jun 30, 2018 | $0.61 | +19.6% |
| Q1 FY2018 | Mar 31, 2018 | $0.60 | +25.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.30 | +160.0% |
| Q3 FY2017 | Sep 30, 2017 | $0.50 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.51 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.48 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.50 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?